Eleni Gourni

8PUBLICATIONS
11CO-AUTHORS
Functional materialsMolecular targetsPharmacogenomicsRadiation therapySatellite, space vehicle and missile design and testing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Optimizing FAPI homodimers for theranostic applications: The impact of the linker design in DOTAGA.Glu2.(FAPI)2 and DOTAGA.PEG2.Glu.(FAPI)2.

|Jan 15, 2026
Preclinical Evaluation of a 177Lu-Labeled Gastrin-Releasing Peptide Receptor Antagonist and Prostate Cancer Treatment with Monotherapy and in Combination with Everolimus.

Naveen Kumar, Adrianna Bilinska, Elena Menéndez

|Nov 11, 2025
A true theranostic pair - 44/47Sc-labeled GRPR antagonist shows great promise for managing prostate and breast cancer.

Naveen Kumar, Adrianna Bilinska, Elena Menéndez

|Oct 17, 2025
Preclinical evaluation of DOTAGA.Glu.(FAPI)2 and DO3A.Glu.(FAPI)2 as theranostics with human dosimetry extrapolation to lutetium-177 and terbium-161 analogs.

Adrianna Bilinska, Naveen Kumar, Silvano Gnesin

|Feb 25, 2025
Improved FAPI-radiopharmaceutical pharmacokinetics from the perspectives of a dose escalation study.

Adrianna Bilinska, Sanjana Ballal, Chandrasekhar Bal

|Jun 07, 2023
Translational assessment of a DATA-functionalized FAP inhibitor with facile

Alondra Escudero-Castellanos, Jens Kurth, Surachet Imlimthan

Pageof 2

Frequent Collaborators

1 joint publications

Gabriele Birindelli

1 joint publications

Milos Drobnjakovic

1 joint publications

Volker Morath

1 joint publications

Katja Steiger